C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2004
12/30/2004	US20040265801 Immunoassays for anti-HCV antibodies
12/30/2004	US20040265791 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products
12/30/2004	US20040265787 Immortalized human keratinocyte cell line
12/30/2004	US20040265786 Method and formulation for lyophilizing cultured human cells to preserve RNA and DNA contained in cells for use in molecular biology experiments
12/30/2004	US20040265332 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitidis
12/30/2004	US20040265331 BASB027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
12/30/2004	US20040265330 Novel compounds
12/30/2004	US20040265316 An antibody which specifically binds to a Fhit (fragile histidine triad) protein or derivative
12/30/2004	US20040265307 Anti-IGF-I receptor antibody
12/30/2004	US20040265305 Inhibiting fibrosis, scleroderma, sarcoidosis, ankylosing spondilitis; monitoring the efficacy of the treatment; bioassay
12/30/2004	US20040265303 Anti-CCR2 antibodies and methods of use therefor
12/30/2004	US20040265300 Targeting cancer cell; induction or prevention of apoptosis in eukaryotic cells; a fusion peptide contains a viral apoptotic peptide and an antibody fragment; recombinant host cell comprising the vector, encoding chimeric polypeptide; bioassay monitoring apoptosis activity; drug target
12/30/2004	US20040265288 A engineered cell or recombinant virus as biodrug for the treatment of cancer, HIV infection, multiple sclerosis; drug target
12/30/2004	US20040265287 Myocardial grafts and cellular compositions useful for same
12/30/2004	US20040265284 Methods for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains
12/30/2004	US20040265281 System capable of treating and defining various diseases using stem cells
12/30/2004	US20040263957 Method and system for simultaneously imaging multiple views of a plant embryo
12/30/2004	US20040261799 Intrauterine device, method of making such a device and method for putting active elements within the uterine cavity
12/30/2004	CA2471352A1 Method and system for three-dimensionally imaging an apical dome of a plant
12/30/2004	CA2470448A1 Use of a abscisic acid in somatic embryogenesis of pine trees
12/29/2004	WO2004113552A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
12/29/2004	WO2004113543A1 Plant lipase
12/29/2004	WO2004113517A2 IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA
12/29/2004	WO2004113516A1 Porcine islets cultured with porcine sertoli cells for xenotransplantation
12/29/2004	WO2004113515A2 Tissue modeling in embryonic stem (es) cell system
12/29/2004	WO2004113514A1 Reconstructed dermal papillae
12/29/2004	WO2004113513A2 Methods and compositions for modulating stem cell growth and differentiation
12/29/2004	WO2004113512A2 Method of generating islet beta-cells from exocrine pancreatic cells
12/29/2004	WO2004113511A2 Cell line and uses thereof
12/29/2004	WO2004113507A1 Pharmaceutically compatible method for purifying intact bacterial minicells
12/29/2004	WO2004113500A2 B7s1: an immune modulator
12/29/2004	WO2004113493A2 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site
12/29/2004	WO2004113380A1 Use of cardiotrophin to modulate stem cell proliferation
12/29/2004	WO2004112748A2 Rate controlled release of a pharmaceutical agent in a biodegradable device
12/29/2004	WO2004099418A8 Fused protein
12/29/2004	WO2004096833A3 Inducers of recombinant protein expression
12/29/2004	WO2004096124A3 Compositions and methods for the diagnosis and treatment of tumor
12/29/2004	WO2004090126A8 Phosphodiesterase 10a7 isoforms and methods of use
12/29/2004	WO2004090121A3 Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same
12/29/2004	WO2004082640A3 Human serum albumin conjugates with therapeutic compounds
12/29/2004	WO2004065590A3 Activation and expansion of t cells
12/29/2004	WO2004047622A3 Substantially non-immunogenic injectable collagen
12/29/2004	WO2004042004A3 Mouse model for autoimmune disorders
12/29/2004	WO2004016803A3 Method of enhancing cd4+ t cell responses
12/29/2004	WO2004015072A3 Mrbs as modifiers of the rb pathway and methods of use
12/29/2004	WO2004007682A3 Methods and compositions for modulating t helper (th) cell development and function
12/29/2004	WO2004001014A3 Osteopontin, oligodendrocytes and myelination
12/29/2004	WO2003092542A8 Injectable chondrocyte implant
12/29/2004	WO2003087392A9 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
12/29/2004	WO2003057178A3 Viral capsid assembly intermediates
12/29/2004	WO2003057146A3 Novel compositions and methods for cancer
12/29/2004	WO2002089747A3 Compositions and methods for the therapy and diagnosis of prostate cancer
12/29/2004	WO2000061774A3 Bone morphogenic proteins
12/29/2004	EP1491632A2 Anti-alphavbeta3 humanized monoclonal antibodies
12/29/2004	EP1491624A1 Method of culturing liver cells over long time
12/29/2004	EP1491556A1 Humanized immunoglobulins and their production and use
12/29/2004	EP1491555A1 Anti-human hepatoma monoclonal antibody hab18 light/heavy chain variable region gene, and use thereof
12/29/2004	EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/29/2004	EP1491089A1 Media comprising gellan gum and methods for promoting maturation of conifer somatic embryos
12/29/2004	EP1490690A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap
12/29/2004	EP1490689A1 Novel compositions and methods in cancer associated with altered expression of prlr
12/29/2004	EP1490688A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
12/29/2004	EP1490686A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
12/29/2004	EP1490677A2 Computational method for designing enzymes for incorporation of amino acid analogs into proteins
12/29/2004	EP1490520A2 Assay device that analyzes the absorption, metabolism, permeability and/or toxicity of a candidate compound
12/29/2004	EP1490506A2 Method for generating primate trophoblasts
12/29/2004	EP1490500A1 Novel compositions and methods in cancer associated with altered expression of tbx21
12/29/2004	EP1490497A2 Egvi endoglucanase and nucleic acids encoding the same
12/29/2004	EP1490492A2 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
12/29/2004	EP1490490A2 Antisense iap nucleobase oligomers and uses thereof
12/29/2004	EP1490487A1 A method for selecting cell lines to be used for nuclear transfer in mammalian species
12/29/2004	EP1490486A2 Method of identifying genes controlling diferentiation
12/29/2004	EP1490483A2 In vivo incorporation of unnatural amino acids
12/29/2004	EP1490482A1 Host cells having improved cell survival properties and methods to generate such cells
12/29/2004	EP1490481A2 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
12/29/2004	EP1490480A2 Primitive and proximal hepatic stem cells
12/29/2004	EP1490479A1 Dedifferentiated, programmable stem cells having a monocytic origin and the production and use thereof
12/29/2004	EP1490478A2 Method for production of neutrophils and uses therefor
12/29/2004	EP1490477A2 Redifferentiated cells for repairing cartilage defects
12/29/2004	EP1490476A2 Endothelial cells derived from human embryonic stem cells
12/29/2004	EP1490475A2 Muscle cells and their use in cardiac repair
12/29/2004	EP1490474A2 Method for producing pseudo islets
12/29/2004	EP1490471A2 Fabrication of vascularized tissue using microfabricated two-dimensional molds
12/29/2004	EP1490405A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
12/29/2004	EP1490395A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
12/29/2004	EP1490394A1 Method and apparatus for the identification and qualification of biomolecules
12/29/2004	EP1490388A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
12/29/2004	EP1490386A2 Novel polypeptides and nucleic acids encoding the same
12/29/2004	EP1490381A1 Human gene critical to fertility
12/29/2004	EP1490110A2 Anti-alpha v beta 6 antibodies
12/29/2004	EP1490107A1 Modulating angiogenesis
12/29/2004	EP1490099A2 Human monoclonal antibodies to influenza m2 protein and methods of making and using same
12/29/2004	EP1490088A2 Dentritic cell nodes
12/29/2004	EP1490085A2 Fc receptor homolog, reagents, and uses thereof
12/29/2004	EP1490074A2 Mixed- cell gene therapy
12/29/2004	EP1490013A2 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea
12/29/2004	EP1490005A2 Methods and devices for selective disruption of fatty tissue by controlled cooling
12/29/2004	EP1379140A4 Production of pancreatic islet cells and delivery of insulin
12/29/2004	EP1373528A4 Novel expression vectors
12/29/2004	EP1255821B1 Protein c derivatives

1 ... 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 ... 1827